Supply of Red Cell Reagent Panels for Antibody Identification

The contract calls for the supply of characterized red blood cell panels specifically designed for identifying unexpected antibodies in patient sera, a critical function in transfusion medicine and patient safety. These reagent panels must meet precise characterization standards to ensure accurate and reliable antibody detection across diverse clinical samples, supporting diagnostic workflows in blood bank and laboratory settings. The requirement is structured as a subcontract under the Department of Veterans Affairs, with performance centered in Jackson, Mississippi, at the ZIP code 39216, and governed under NAICS code 325413, which pertains to pharmaceutical and medicine manufacturing. The solicitation was posted on July 10, 2026, with responses due by July 15, 2026, indicating a tightly constrained timeline for vendor submissions. While no specific set-aside provisions or agency contacts are detailed, the contract is managed by the 256-NETWORK Contract Office 16, signaling its integration into broader VA healthcare supply infrastructure. The panels must be consistently reliable, traceable, and compliant with applicable clinical and regulatory benchmarks to support the VA’s mission of delivering high-quality blood transfusion services to veteran populations.